Private Trust Company’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Private Trust Company’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,898	Closed	-$562K	–	341
2014 Q4	$562K	Buy	4,898 +4,892	+81,533%	+$593K	0.18%	148
2014 Q3	$1K	Buy	6 +3	+100%	+$435	﹤0.01%	1886
2014 Q2	$0	Sell	3 -21	-88%	-$2.32K	﹤0.01%	2047
2014 Q1	$2K	Hold	24	–	–	﹤0.01%	1558
2013 Q4	$2K	Sell	24 -12	-33%	-$957	﹤0.01%	1567
2013 Q3	$2K	Buy	36 +11	+44%	+$758	﹤0.01%	1521
2013 Q2	$2K	Buy	+25	New	+$1.43K	﹤0.01%	1455

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Private Trust Company's SLXP Position: Q1 2015 in Review

Private Trust Company sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 4,898 shares — an estimated $562K sold.

Private Trust Company first reported a position in SLXP in Q2 2013 and held it in 7 quarters. The position peaked at $562K in Q4 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

Private Trust Company reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
Private Trust Company sold 4,898 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $562K.
Private Trust Company first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 7 quarters.
Private Trust Company's SALIX PHARMACEUTICALS LTD DEL position peaked at $562K in Q4 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Private Trust Company's 13F filing for Q1 2015, filed 9 Apr 2015.